Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
Authors
Khan, SamsuddinDas, Mrinalini
Andries, Aristomo
Deshpande, Alaka
Mansoor, Homa
Saranchuk, Peter
Isaakidis, Petros
Issue Date
2014-07-30
Metadata
Show full item recordJournal
Global Health ActionAbstract
There are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Médecins Sans Frontières (MSF) HIV/tuberculosis programme in Mumbai, India, has been providing third-line ART to patients in care.Publisher
Co-Action PublishingPubMed ID
25084835Language
enISSN
1654-9880Collections
Related articles
- Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.
- Authors: Gill N, Van den Bergh R, Wut Yee Kyaw K, Laxmeshwar C, Das M, Rastogi S, Arago Galindo M, Mansoor H, Kalon S, Isaakidis P
- Issue date: 2019
- Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India.
- Authors: Laxmeshwar C, Acharya S, Das M, Keskar P, Pazare A, Ingole N, Mehta P, Gori P, Mansoor H, Kalon S, Singh P, Mathur T, Ferlazzo G, Isaakidis P
- Issue date: 2020
- HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
- Authors: Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, Phanuphak P, Merati T, Ratanasuwan W, Lee CK, Ditangco R, Mustafa M, Singtoroj T, Kiertiburanakul S, TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).
- Issue date: 2014
- Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
- Authors: Boyd MA, Moore CL, Molina JM, Wood R, Madero JS, Wolff M, Ruxrungtham K, Losso M, Renjifo B, Teppler H, Kelleher AD, Amin J, Emery S, Cooper DA, SECOND-LINE study group.
- Issue date: 2015 Feb
- Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
- Authors: Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D
- Issue date: 2016 Sep